Position in EXEL
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$611,405
+$310,446 QoQ
Shares Held
11,237
+60.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#399
of 751 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL SECURITIES, INC. holds $9,913,561 across 11 Biotechnology names. EXEL ranks #6 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,982 | $2,971,438 | |
| 2 | RPRX |
Royalty Pharma plc
|
35,574 | $1,994,634 | |
| 3 | ARGX |
Argenx SE
|
1,295 | $1,201,462 | |
| 4 | INSM |
INSMED Inc
|
6,728 | $717,339 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,028 | $640,999 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
11,237 | $611,405 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
5,720 | $497,354 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,389 | $418,130 |
All Filings in EXEL
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $611,405 | 11,237 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $300,959 | 7,017 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $357,258 | 8,151 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $197,414 | 4,780 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $135,237 | 3,068 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $35,701 | 967 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $32,201 | 967 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $15,414 | 594 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $10,605 | 472 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $21,641 | 912 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||